Effects of Treatment of Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes With Metformin Alone or in Combination With Insulin Glargine on β-Cell Function: Comparison of Responses In Youth And Adults
Year: 2019
Type: article
Abstract: = 132) with IGT or recently diagnosed type 2 diabetes were randomized to 3 months of insulin glargine followed by 9 months of metformin, or 12 months of metformin. Hyperglycemic clamps conducted at baseline, after 12 months of medication, and 3 months after medication withdrawal assessed β-cell function as steady-state and maximal C-peptide responses adjusted for insulin sensitivity. Temporal changes in β-cell function were distinctly different. In youth, β-cell function deteriorated during treatment and after treatment withdrawal, with no differences between treatment groups. In adults, β-cell function improved during treatment, but this was not sustained after treatment withdrawal. The difference in β-cell function outcomes in response to medications in youth versus adults supports a more adverse trajectory of β-cell deterioration in youth.
Source: Diabetes
DOI: 10.2337/db19-0299
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment, Indiana Clinical and Translational Sciences Institute, RISE: The Restoring Insulin Secretion Pediatric Medication Study, Re-Engineering Translational Research at the University of Chicago, Preservation of Beta Cell Function in Prediabetes Early Type 2 Diabetes, The Next Generation of Innovative Cardiovascular Clinical/Translational Researchers, Optimizing Recovery and Preservation of Endogenous Insulin Secretion, Colorado Clinical and Translational Sciences Institute, G650349462, Beta Cell Restoration through Fat Mitigation, University of Pittsburgh Clinical and Translational Science Institute, J. NRSA Training Core, Diabetes Research Center, Southern California Clinical and Translational Science Institute, Indiana Diabetes Research Center, Yale Clinical and Translational Science Award, Diabetes Research and Training Center , Yale Diabetes Research Center
OpenAlex ID: W4237421206
